Paper Details

  1. Home
  2. Paper Details

Topical therapy of atopic dermatitis with a focus on pimecrolimus.

Author: BieberT, EichenfieldL F, IrvineA D, LugerT, PallerA S, SidburyR, WerfelT

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

Topical calcineurin inhibitors, such as pimecrolimus, are effective in treating atopic dermatitis (AD). They have similar anti-inflammatory effects to topical corticosteroids, reduce pruritus, and improve quality of life. Pimecrolimus is steroid-sparing and has a good safety profile, making it a preferred therapy for children and sensitive skin areas.
Paper Details　
Original Abstract of the Article :
Atopic dermatitis (AD) is a chronic and relapsing, inflammatory skin disease characterized by impaired skin barrier function and immune system dysregulation that results in dryness, skin microbiome dysbiosis and intense pruritus. It is highly heterogeneous, and its management is demanding. Patients ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1111/jdv.17272

データ提供：米国国立医学図書館（NLM）

Pimecrolimus: A Topical Oasis for Atopic Dermatitis

Atopic dermatitis (AD) can be a real itch, literally! This study delves into the desert of skin conditions to explore the effectiveness of pimecrolimus, a topical treatment for AD. The authors investigated how pimecrolimus combats the dry, itchy, and inflamed skin associated with AD. This investigation is crucial as AD can significantly impact quality of life, and current treatments can have side effects.

A Gentle Approach to Atopic Dermatitis

The study found that pimecrolimus effectively reduces inflammation and itching, improving quality of life for AD patients. The research showed that pimecrolimus has a favorable safety profile compared to other medications, with no evidence of increased cancer risk or skin infections. In fact, it’s like a refreshing oasis in the desert of skin treatments.

Embracing Pimecrolimus

For those with AD, pimecrolimus provides a gentle yet effective way to manage symptoms. It’s a valuable tool for navigating the challenges of this condition. This research highlights the importance of finding the right treatment for each person based on their individual needs and sensitivities.

Dr.Camel's Conclusion

Pimecrolimus offers a promising oasis for those battling the desert of atopic dermatitis. It provides a gentle and effective way to manage the symptoms and improve quality of life. The research is crucial for further understanding this treatment and its role in managing AD.

Date :
  1. Date Completed 2021-06-21
  2. Date Revised 2021-06-21
Further Info :

Pubmed ID

33834524

DOI: Digital Object Identifier

10.1111/jdv.17272

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.